These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6959195)

  • 1. Kinetics of citalopram in man; plasma levels in patients.
    Fredricson Overø K
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(3):311-8. PubMed ID: 6959195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The kinetics of citalopram: single and multiple dose studies in man.
    Kragh-Sørensen P; Overø KF; Petersen OL; Jensen K; Parnas W
    Acta Pharmacol Toxicol (Copenh); 1981 Jan; 48(1):53-60. PubMed ID: 6939299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary studies of the kinetics of citalopram in man.
    Overø KF
    Eur J Clin Pharmacol; 1978 Nov; 14(1):69-73. PubMed ID: 729609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of citalopram in elderly patients.
    Fredericson Overø K; Toft B; Christophersen L; Gylding-Sabroe JP
    Psychopharmacology (Berl); 1985; 86(3):253-7. PubMed ID: 3929295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Citalopram--a highly selective 5-HT uptake inhibitor--in the treatment of depressed patients.
    Dufour H; Bouchacourt M; Thermoz P; Viala A; Phak Rop P; Gouezo F; Durand A; Høpfner Petersen HE
    Int Clin Psychopharmacol; 1987 Jul; 2(3):225-37. PubMed ID: 3320186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of citalopram in test animals; drug exposure in safety studies.
    Fredricson Overø K
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(3):297-309. PubMed ID: 6959194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-performance liquid chromatographic determination of citalopram and four of its metabolites in plasma and urine samples from psychiatric patients.
    Oyehaug E; Ostensen ET; Salvesen B
    J Chromatogr; 1984 Jun; 308():199-208. PubMed ID: 6589233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose morphine and methadone in cancer patients. Clinical pharmacokinetic considerations of oral treatment.
    Säwe J
    Clin Pharmacokinet; 1986; 11(2):87-106. PubMed ID: 3514045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between clinical effects, serum drug concentration and serotonin uptake inhibition in depressed patients treated with citalopram. A double-blind comparison of three dose levels.
    Bjerkenstedt L; Flyckt L; Overø KF; Lingjaerde O
    Eur J Clin Pharmacol; 1985; 28(5):553-7. PubMed ID: 3899675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salivation after single-doses of the new antidepressants femoxetine, mianserin and citalopram. A cross-over study.
    Clemmesen L; Jensen E; Min SK; Bolwig TG; Rafaelsen OJ
    Pharmacopsychiatry; 1984 Jul; 17(4):126-32. PubMed ID: 6591216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-dose and steady-state pharmacokinetics of tomoxetine in normal subjects.
    Farid NA; Bergstrom RF; Ziege EA; Parli CJ; Lemberger L
    J Clin Pharmacol; 1985; 25(4):296-301. PubMed ID: 4008676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetics of clofarabine and its metabolite 6-ketoclofarabine in adult and pediatric patients with cancer.
    Bonate PL; Cunningham CC; Gaynon P; Jeha S; Kadota R; Lam GN; Razzouk B; Rytting M; Steinherz P; Weitman S
    Cancer Chemother Pharmacol; 2011 Apr; 67(4):875-90. PubMed ID: 20582417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose independent pharmacokinetics of mexiletine in healthy volunteers.
    Pringle T; Fox J; McNeill JA; Kinney CD; Liddle J; Harron DW; Shanks RG
    Br J Clin Pharmacol; 1986 Mar; 21(3):319-21. PubMed ID: 3964531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of citalopram in the blood serum and in the central nervous system of rats after single and multiple dosage.
    Melzacka M; Rurak A; Adamus A; Daniel W
    Pol J Pharmacol Pharm; 1984; 36(6):675-82. PubMed ID: 6598490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoxetine kinetics and protein binding in normal and impaired renal function.
    Aronoff GR; Bergstrom RF; Pottratz ST; Sloan RS; Wolen RL; Lemberger L
    Clin Pharmacol Ther; 1984 Jul; 36(1):138-44. PubMed ID: 6610522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Citalopram versus mianserin. A controlled, double-blind trial in depressed patients.
    de Wilde J; Mertens C; Overø KF; Petersen HE
    Acta Psychiatr Scand; 1985 Jul; 72(1):89-96. PubMed ID: 3898725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dextropropoxyphene kinetics after single and repeated oral doses in man.
    Brøsen K; Gram LF; Schou J; Larsen NE; Thayssen P
    Eur J Clin Pharmacol; 1985; 29(1):79-84. PubMed ID: 4054208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of the antidepressant agent citalopram and metabolites in plasma by liquid chromatography with fluorescence detection.
    Oyehaug E; Ostensen ET; Salvesen B
    J Chromatogr; 1982 Jan; 227(1):129-35. PubMed ID: 6948816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Citalopram pharmacokinetics in patients with chronic renal failure and the effect of haemodialysis.
    Spigset O; Hägg S; Stegmayr B; Dahlqvist R
    Eur J Clin Pharmacol; 2000 Dec; 56(9-10):699-703. PubMed ID: 11214779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of citalopram, amitriptyline and clomipramine in plasma by reversed-phase high-performance liquid chromatography.
    Rop PP; Viala A; Durand A; Conquy T
    J Chromatogr; 1985 Feb; 338(1):171-8. PubMed ID: 3860507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.